Project Grant R21HD115129
Award Date
5/1/25
Completion Date
4/30/27
Dollars Obligated
$255K
Federal Agency
National Institute of Child Health and Human Development
Federal Grant Program
93.865
Assistance Type
Project Grant
Place of Performance
Columbia, MO 65211, USA
Similar Awards
This $675,157 Project Grant award from the National Institute of Child Health and Human Development (CFDA 93.865 - Child Health and Human Development Extramural Research) to The Trustees of the University of Pennsylvania aims to assess the feasibility and efficacy of using in vivo gene editing techniques, such as adenine base editing and prime editing, to permanently correct the most common pathogenic variant (R408W) of the phenylalanine hydroxylase (PAH) gene in human hepatocytes. The goal is...
This federal Project Grant award from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), aims to investigate the neural mechanisms underlying impaired satiation in individuals with genetic disorders such as Prader-Willi syndrome (PWS) and Schafer-Yoder syndrome (SYS). The $223,446 award, effective from September 1, 2024, to August 31, 2026, will be utilized by the University of Arizona to...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) provides $501,985.34 to the University of Arkansas to conduct research on the structural consequences of protein kinase C (PKC)-dependent phosphorylation of the Kv7.2 ion channel. The research aims to elucidate how phosphorylation affects the binding of critical signaling cofactors like calmodulin and phosphatidylinositol 4,5-bisphosphate to the...
This federal Project Grant award, valued at $526,008.00, was issued by the National Institute of Child Health and Human Development under the Child Health and Human Development Extramural Research program (CFDA 93.865). The grant supports research to investigate the role of the METTL3 gene in mammalian placenta development and maintenance across pregnancy, with a focus on understanding how alterations in METTL3 function may contribute to pregnancy-associated disorders like intrauterine growth...
This Project Grant award, made by the National Institute on Aging (CFDA 93.866 - Aging Research), is focused on establishing the feasibility and reproducibility of using hyperpolarized 13C pyruvate magnetic resonance imaging (MRI) to assess brain glucose metabolism in normal human subjects. The $233,250 award, with a performance period from September 2024 to June 2026, will support two key aims: 1) in vitro testing using a 3D-printed phantom to evaluate the signal dynamics of this imaging...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) provides $390,000.00 in funding to the University of Colorado-Denver to support research aimed at improving the derivation, analysis, and interpretation of phenotypes and their associations with markers of human health. The key goals of the research over the next 5 years include: 1) developing methods to optimize phenotype pre-processing using...
This federal Project Grant award, provided by the National Institute of Mental Health (NIMH) under CFDA Program 93.242 Mental Health Research Grants, supports research to investigate the role of the PERK kinase in HIV-induced neuroinflammation and neurocognitive impairment (NCI). The Trustees of the University of Pennsylvania, along with sub-awardees Cleveland Clinic Lerner College of Medicine, will receive $745,822 over the award period from Jan 1, 2025 to Dec 31, 2029 to conduct this research....
This $479,164 federal Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) will support research to identify genetic factors that influence behavioral outcomes in individuals with prenatal alcohol exposure (PAE). The key objectives are to: 1) Explore additional choline-related genetic polymorphisms that may modulate cognition and behavior in those with PAE, and 2) Directly test the influence of the ALDH1L1 gene,...
This federal Project Grant award, funded by the National Human Genome Research Institute (NHGRI) under the Human Genome Research program (CFDA 93.172), supports research to understand how adults with childhood-onset genetic diseases, specifically cystic fibrosis (CF), conceptualize their futures and make life decisions amid evolving prognoses. The $174,302 award, effective March 7, 2025 through February 28, 2030, will enable qualitative interviews with 45 adult CF patients and 30 CF clinicians...
This federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $225,304 in funding to Northwestern University to characterize the functional consequences of autosomal dominant polycystic kidney disease (ADPKD) disease-causing variants using a novel synthetic biology approach. The key objectives of this award are to: 1) Implement a cell-free...